CRC has an immunosuppressive TME which helps prevent the event of a successful reaction to ICB therapies. There may be Hence an urgent must establish the means reprogram this suppressive TME as a way to enrich immunotherapy efficacy. In the current review, we made use of CRISPR KO screens to https://alexisn419chm2.newsbloger.com/profile